Abstract:The skeletal system is the basis of the vertebral body composition, which affords stabilization sites for muscle attachment, protects vital organs, stores mineral ions, supplies places to the hematopoietic system, and participates in complex endocrine and immune system. Not surprisingly, bones are constantly reabsorbed, formed, and remodeled under physiological conditions. Once bone metabolic homeostasis is interrupted (including inflammation, tumors, fractures, and bone metabolic diseases), the body rapidly initiates bone regeneration to maintain bone tissue structure and quality. Macroautophagy/autophagy is an essential metabolic process in eukaryotic cells, which maintains metabolic energy homeostasis and plays a vital role in bone regeneration by controlling molecular degradation and organelle renewal. One relatively new observation is that mesenchymal cells, osteoblasts, osteoclasts, osteocytes, chondrocytes, and vascularization process exhibit autophagy, and the molecular mechanisms and targets involved are being explored and updated. The role of autophagy is also emerging in degenerative diseases (intervertebral disc degeneration [IVDD], osteoarthritis [OA], etc.) and bone metabolic diseases (osteoporosis [OP], osteitis deformans, osteosclerosis). The use of autophagy regulators to modulate autophagy has benefited bone regeneration, including MTOR (mechanistic target of rapamycin kinase) inhibitors, AMPK activators, and emerging phytochemicals. The application of biomaterials (especially nanomaterials) to trigger autophagy is also an attractive research direction, which can exert superior therapeutic properties from the material-loaded molecules/drugs or the material's properties such as shape, roughness, surface chemistry, etc. All of these have essential clinical significance with the discovery of autophagy associated signals, pathways, mechanisms, and treatments in bone diseases in the future. Abbreviations: Δψm: mitochondrial transmembrane potential AMPK: AMP-activated protein kinase ARO: autosomal recessive osteosclerosis ATF4: activating transcription factor 4 ATG: autophagy-related β-ECD: β-ecdysone BMSC: bone marrow mesenchymal stem cell ER: endoplasmic reticulum FOXO: forkhead box O GC: glucocorticoid HIF1A/HIF-1α: hypoxia inducible factor 1 subunit alpha HSC: hematopoietic stem cell HSP: heat shock protein IGF1: insulin like growth factor 1 IL1B/IL-1β: interleukin 1 beta IVDD: intervertebral disc degradation LPS: lipopolysaccharide MAPK: mitogen-activated protein kinase MSC: mesenchymal stem cell MTOR: mechanistic target of rapamycin kinase NP: nucleus pulposus NPWT: negative pressure wound therapy OA: osteoarthritis OP: osteoporosis PTH: parathyroid hormone ROS: reactive oxygen species SIRT1: sirtuin 1 SIRT3: sirtuin 3 SQSTM1/p62: sequestosome 1 TNFRSF11B/OPG: TNF receptor superfamily member 11b TNFRSF11A/RANK: tumor necrosis factor receptor superfamily, member 11a TNFSF11/RANKL: tumor necrosis factor (ligand) superfamily, member 11 TSC1: tuberous sclerosis complex 1 ULK1: unc-51 like autophagy activating kinase 1

TMEM175 plays a crucial role in osteoblast differentiation by regulating lysosomal function and autophagy

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

TMEM135 Maintains the Equilibrium of Osteogenesis and Adipogenesis by Regulating Mitochondrial Dynamics

TMEM165 replenishes lysosomal calcium stores, protects cells against calcium overload, and mediates calcium-induced lysosomal H+ leakage

TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis

TMCO1-mediated Ca2+ Leak Underlies Osteoblast Functions Via CaMKII Signaling

TMEM18 Inhibits Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells by Inactivating Β-Catenin

TMEM166, a Novel Transmembrane Protein, Regulates Cell Autophagy and Apoptosis

Loss of TMEM126A Promotes Extracellular Matrix Remodeling, Epithelial-to-mesenchymal Transition, and Breast Cancer Metastasis by Regulating Mitochondrial Retrograde Signaling

CMTM3 Suppresses Bone Formation and Osteogenic Differentiation of Mesenchymal Stem Cells Through Inhibiting Erk1/2 and RUNX2 Pathways

TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration

Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism

Intracellular TMEM16A is necessary for myogenesis of skeletal muscle

Defective Autophagy in Osteoblasts Induces Endoplasmic Reticulum Stress and Causes Remarkable Bone Loss

The role of autophagy in bone metabolism and clinical significance

TMEM16A Regulates Satellite Cell-Mediated Skeletal Muscle Regeneration by Ensuring a Moderate Level of Caspase 3 Activity.

Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders

Systemic knockout of Tmem175 results in aberrant differentiation but no effect on hematopoietic reconstitution

Matrix Remodeling Associated 7 Promotes Differentiation Of Bone Marrow Mesenchymal Stem Cells Toward Osteoblasts

TMEM189 Negatively Regulates the Stability of ULK1 Protein and Cell Autophagy.

Expression of TMEM166 protein in human normal and tumor tissues.